IFNG and acute myeloid leukemia: We had previously shown that the Type II interferon IFNγ led to strong upregulation of CD38 on AML cells, which subsequently facilitated cytotoxicity of AML cells amongst themselves upon addition of the anti-CD38 antibody daratumumab [3].